Latest News for: him her

Edit

Companies are ignoring your privacy demands. No one is stopping them

Jewish World Review 04 Apr 2025
They took that as a sign that companies including American Eagle, Macy's, Ford, Uniqlo and telehealth provider Hims & Hers didn't consistently comply with legally enforceable opt-out demands.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Hims & Hers Health Inc)

Public Technologies 04 Apr 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 0.5 ... 2 ... Hims & Hers Health, Inc. [HIMS] 5 ... 6 ... Hims & Hers Health Inc.
Edit

Telehealth firm to sell Eli Lilly weight-loss drug on Hims & Hers platform

Business Day 02 Apr 2025
Bengaluru — Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly’s weight-loss drug as it widens its offerings to offset any impact from impending restrictions on selling copies of Novo Nordisk’s obesity drug.
Edit

Hims & Hers shares rise as company adds Eli Lilly's Zepbound

CNBC 02 Apr 2025
CNBC's Brandon Gomez joins 'Closing Bell' to discuss Hims & Hers shares rising as company adds new weight-loss medications to platform ... .
Edit

Hims & Hers Zepbound Offering Won’t Bring Needed Sales Boom, Analysts Say

Wall Street Journal 02 Apr 2025
Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, will struggle to meet its revenue goal ... .
Edit

Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why

The Call 01 Apr 2025
Shares of telehealth company Hims & Hers Health (NYSE ... Is now the time to buy Hims & Hers Health? Access our full analysis report here, it’s free.What The Market Is Telling Us. Hims & Hers ...
Edit

Hims & Hers shares rise as company adds new weight-loss medications to platform

CNBC 01 Apr 2025
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform ... .
Edit

Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform

Wall Street Journal 01 Apr 2025
The telehealth-consultation platform said it plans to continue expanding its weight loss offerings ... .
Edit

Statement: Lilly has no affiliation with hims & hers (Eli Lilly and Company)

Public Technologies 01 Apr 2025
). INDIANAPOLIS, April 1, 2025 - Eli Lilly and Company (NYSE. LLY) has no affiliation with hims & hers. Zepbound (tirzepatide) can be prescribed by any licensed healthcare professional ... About Lilly ... making life better for millions more people ... (noodl.
Edit

1 Stock Under $50 on Our Watchlist and 2 to Turn Down

The Call 31 Mar 2025
Hims & Hers Health (HIMS) ... Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE ... At $27.65 per share, Hims & Hers Health trades at 28.6x forward price-to-earnings.
Edit

Here’s why Hims & Hers stock price has crashed: buy the dip?

Invezz 27 Mar 2025
Hims & Hers stock price has imploded this year, erasing some of the gains made in 2024 when it became one of the top-performing companies in the US ... Is the soaring Hims & Hers stock a good investment?Hims & Hers stock price analysis.
Edit

Why is the NHS still giving into the gender terrorists?

AOL 20 Mar 2025
Better still, Churchill himself observed that “an appeaser is one who feeds a crocodile hoping it will eat him last.” ... Vanishingly few bearded “hims”, “hers” or “thems” rock up in frocks to make a point by sharing their facilities.
Edit

Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get

Newsday 19 Mar 2025
Large-scale providers of tirzepatide and semaglutide such as San Francisco-based Hims & Hers are among those whose compounded medications comes from outsourcers ... Prescribers are contracted by Hims & Hers, the spokesman said by phone.
Edit

‘I really trusted him’: Her sister’s quick thinking saved her from a scammer

Straits Times 19 Mar 2025
Bank’s scam prevention effort seek to protect the hard-earned life savings of seniors in Singapore ....
Edit

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

The Call 18 Mar 2025
Shares of telehealth company Hims & Hers Health (NYSE ... Food and Drug Administration raised concerns about unapproved GLP-1 drugs used for weight loss, including versions (compounded) prescribed by Hims & Hers.

Article Search

tools
×
×
×
×